Volume 1, Issue 1 (1-2023)                   Neuroscience Updates 2023, 1(1): 39-49 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rostami Mehr S, Ghalami F, Abbasi-Maleki S, Saadat M. Investigating the neuroprotective, anti-inflammatory, and antioxidant effects of Agaricus bisporus mushroom in the Rat Model of Parkinson's Disease. Neuroscience Updates 2023; 1 (1) :39-49
URL: http://neuroupdates.de/article-1-109-en.html
Investigating the neuroprotective, anti-inflammatory, and antioxidant effects of Agaricus bisporus mushroom in the Rat Model of Parkinson's Disease
Samira Rostami Mehr1 , Fatemeh Ghalami2 , Saeid Abbasi-Maleki1 , Maryam Saadat *3
1- Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
2- Ramsar International Branch, Mazandaran University of Medical Sciences, Sari, Iran
3- Department of Anatomical Sciences, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
Abstract:   (5426 Views)

Background: Due to the antioxidant and anti-inflammatory properties of Agaricus bisporus mushrooms, there is potential for positive effects in preventing Parkinson's disease. This study aims to investigate the neuroprotective effects of Agaricus bisporus mushrooms in a rotenone-induced model of Parkinson’s disease in rats.

Methods: Rats were divided into five groups: control (CON), rotenone (ROTE), and three groups receiving rotenone and different doses of A. bisporus mushroom (ABM 100, ABM 200, and ABM 300) at doses of 100, 200, and 300 mg/kg, respectively, administered daily for 21 days. Behavioral responses were assessed using the open field test and rotarod test, and various parameters including striatal dopamine, IL-1β, IL-6, TNF-α, malondialdehyde (MDA), reduced glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) were measured. Additionally, the expressions of Drp-1, PGC1α, and TFAM were evaluated.

Results: The results demonstrated that rotenone significantly reduced ambulation, rearing, grooming, and increased immobility time compared to the control group (P=0.001). Rotenone also decreased striatal dopamine content, GSH, SOD, CAT, and increased pro-inflammatory cytokine concentrations compared to the control group (P=0.001). Furthermore, rotenone decreased the expression of Drp-1 and increased the expressions of PGC1α and TFAM compared to the control group (P=0.001).

Conclusion: The use of the mushroom at higher concentrations (200 mg/kg and 300 mg/kg) reversed the effects of rotenone, suggesting that this mushroom may be utilized for preventing Parkinson's disease at higher doses.

Keywords: Parkinson's Disease, Mushroom, Inflammation, Rat
Full-Text [PDF 611 kb]   (2099 Downloads)    
Type of Study: Original Article | Subject: Neurodegenerative Disease
Received: 2023/10/10 | Accepted: 2023/12/15 | Published: 2023/12/20
References
1. Garza-Ulloa J. Update on Parkinson's disease. American Journal of Biomedical Science and Research. 2019;2(6):27-31. [DOI:10.34297/AJBSR.2019.02.000614]
2. Rascol O, Fabbri M, Poewe W. Amantadine in the treatment of Parkinson's disease and other movement disorders. The Lancet Neurology. 2021;20(12):1048-56. [DOI:10.1016/S1474-4422(21)00249-0] [PMID]
3. Hanikoğlu A, Delen E. Biochemical perspective on Parkinson's disease. Multidisciplinary Approach in Medical Science III. 2023.
4. Doric Z, Nakamura K. Mice with disrupted mitochondria used to model Parkinson's disease. Nature Publishing Group UK London; 2021. [DOI:10.1038/d41586-021-02955-z] [PMID]
5. Latif S, Jahangeer M, Razia DM, Ashiq M, Ghaffar A, Akram M, et al. Dopamine in Parkinson's disease. Clinica chimica acta. 2021;522:114-26. [DOI:10.1016/j.cca.2021.08.009] [PMID]
6. Khatri DK, Choudhary M, Sood A, Singh SB. Anxiety: An ignored aspect of Parkinson's disease lacking attention. Biomedicine & Pharmacotherapy. 2020;131:110776. [DOI:10.1016/j.biopha.2020.110776] [PMID]
7. Patrick KL, Bell SL, Weindel CG, Watson RO. Exploring the "multiple-hit hypothesis" of neurodegenerative disease: bacterial infection comes up to bat. Frontiers in Cellular and Infection Microbiology. 2019;9:138. [DOI:10.3389/fcimb.2019.00138] [PMID] [PMCID]
8. Masato A, Plotegher N, Boassa D, Bubacco L. Impaired dopamine metabolism in Parkinson's disease pathogenesis. Molecular neurodegeneration. 2019;14(1):1-21. [DOI:10.1186/s13024-019-0332-6] [PMID] [PMCID]
9. Lehrer S, Rheinstein PH. Shingles vaccination reduces the risk of Parkinson's disease. Chronic Diseases and Translational Medicine. 2023;9(01):54-7. [DOI:10.1002/cdt3.50] [PMID]
10. Dhailappan A, Samiappan S. Impact of Diet on Neurotransmitters. Role of Nutrients in Neurological Disorders: Springer; 2022. p. 363-83. [DOI:10.1007/978-981-16-8158-5_20]
11. Herz DM, Brown P. Moving, fast and slow: behavioural insights into bradykinesia in Parkinson's disease. Brain. 2023:awad069. [DOI:10.1093/brain/awad069] [PMID] [PMCID]
12. Malar DS, Prasanth MI, Brimson JM, Sharika R, Sivamaruthi BS, Chaiyasut C, et al. Neuroprotective properties of green tea (Camellia sinensis) in Parkinson's disease: A review. Molecules. 2020;25(17):3926. [DOI:10.3390/molecules25173926] [PMID] [PMCID]
13. Dorszewska J, Kowalska M, Prendecki M, Piekut T, Kozłowska J, Kozubski W. Oxidative stress factors in Parkinson's disease. Neural regeneration research. 2021;16(7):1383. [DOI:10.4103/1673-5374.300980] [PMID] [PMCID]
14. Comer AL, Carrier M, Tremblay M-È, Cruz-Martín A. The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation. Frontiers in cellular neuroscience. 2020;14:274. [DOI:10.3389/fncel.2020.00274] [PMID] [PMCID]
15. Alqahtani T, Deore SL, Kide AA, Shende BA, Sharma R, Chakole RD, et al. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis-An updated review. Mitochondrion. 2023. [DOI:10.1016/j.mito.2023.05.007] [PMID]
16. Rokayya S, Khojah E, Elhakem A, Benajiba N, Chavali M, Vivek K, et al. Investigating the nano-films effect on physical, mechanical properties, chemical changes, and microbial load contamination of white button mushrooms during storage. Coatings. 2021;11(1):44. [DOI:10.3390/coatings11010044]
17. Chaudhari AK, Das S, Singh BK, Dubey NK. Green facile synthesis of cajuput (Melaleuca cajuputi Powell.) essential oil loaded chitosan film and evaluation of its effectiveness on shelf-life extension of white button mushroom. Food Chemistry. 2023;401:134114. [DOI:10.1016/j.foodchem.2022.134114] [PMID]
18. Bansal V, Tyagi S, Ghosh K, Gupta A. Extraction of protein from Mushroom and determining its Antioxidant and Anti-Inflammatory Potential. Research Journal of Pharmacy and Technology. 2020;13(12):6017-21. [DOI:10.5958/0974-360X.2020.01049.5]
19. Yusefabad HH, Hosseini SA, Zakerkish M, Cheraghian B, Alipour M. The effects of hot air-dried white button mushroom powder on glycemic indices, lipid profile, inflammatory biomarkers and total antioxidant capacity in patients with type-2 diabetes mellitus: A randomized controlled trial. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences. 2022;27. [DOI:10.4103/jrms.JRMS_513_20] [PMID] [PMCID]
20. Szydłowska-Tutaj M, Szymanowska U, Tutaj K, Domagała D, Złotek U. Influence of Addition of Dried Maitake and Enoki Mushrooms on Antioxidant, Potentially Anti-Inflammatory, and Anti-Cancer Properties of Enriched Pasta. Applied Sciences. 2023;13(14):8183. [DOI:10.3390/app13148183]
21. Issa MY, Ezzat MI, Sayed RH, Elbaz EM, Omar FA, Mohsen E. Neuroprotective effects of Pulicaria undulata essential oil in rotenone model of parkinson's disease in rats: Insights into its anti-inflammatory and anti-oxidant effects. South African Journal of Botany. 2020;132:289-98. [DOI:10.1016/j.sajb.2020.04.032]
22. Iravanpour F, Dargahi L, Rezaei M, Haghani M, Heidari R, Valian N, et al. Intranasal insulin improves mitochondrial function and attenuates motor deficits in a rat 6‐OHDA model of Parkinson's disease. CNS Neuroscience & Therapeutics. 2021;27(3):308-19. [DOI:10.1111/cns.13609] [PMID] [PMCID]
23. Innos J, Hickey MA. Using rotenone to model Parkinson's disease in mice: a review of the role of pharmacokinetics. Chemical Research in Toxicology. 2021;34(5):1223-39. [DOI:10.1021/acs.chemrestox.0c00522] [PMID]
24. von Wrangel C, Schwabe K, John N, Krauss JK, Alam M. The rotenone-induced rat model of Parkinson's disease: behavioral and electrophysiological findings. Behavioural brain research. 2015;279:52-61. [DOI:10.1016/j.bbr.2014.11.002] [PMID]
25. Richter F, Hamann M, Richter A. Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice. Journal of neuroscience research. 2007;85(3):681-91. [DOI:10.1002/jnr.21159] [PMID]
26. Bronner G, Aharon-Peretz J, Hassin-Baer S. Sexuality in patients with Parkinson's disease, Alzheimer's disease, and other dementias. Handbook of clinical neurology. 2015;130:297-323. [DOI:10.1016/B978-0-444-63247-0.00017-1] [PMID]
27. Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, et al. Parkinson disease associated cognitive impairment. Nature Reviews Disease Primers. 2021;7(1):47. [DOI:10.1038/s41572-021-00280-3] [PMID]
28. Tibbles L, Chandler D, Mead A, Jervis M, Boddy L. Evaluation of the behavioural response of the flies Megaselia halterata and Lycoriella castanescens to different mushroom cultivation materials. Entomologia experimentalis et applicata. 2005;116(2):73-81. [DOI:10.1111/j.1570-7458.2005.00272.x]
29. Pasban A, Mohebbi M, Pourazarang H, Varidi M, Abbasi A. Optimization of foaming condition and drying behavior of white button mushroom (A garicus bisporus). Journal of Food Processing and Preservation. 2015;39(6):737-44. [DOI:10.1111/jfpp.12283]
30. Schmidt W, Alam M. Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD). JOURNAL OF NEURAL TRANSMISSION SUPPLEMENTUM. 2006;70:273. [DOI:10.1007/978-3-211-45295-0_42]
31. Sanders LH, Greenamyre JT. Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radical Biology and Medicine. 2013;62:111-20. [DOI:10.1016/j.freeradbiomed.2013.01.003] [PMID] [PMCID]
32. Vacca Jr VM. Parkinson disease: Enhance nursing knowledge. Nursing2022. 2019;49(11):24-32. [DOI:10.1097/01.NURSE.0000585896.59743.21] [PMID]
33. Stahl SM. Dazzled by the dominions of dopamine: clinical roles of D3, D2, and D1 receptors. CNS spectrums. 2017;22(4):305-11. [DOI:10.1017/S1092852917000426] [PMID]
34. Obeso JA, Marin C, Rodriguez‐Oroz C, Blesa J, Benitez‐Temiño B, Mena‐Segovia J, et al. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2008;64(S2):S30-S46. [DOI:10.1002/ana.21481] [PMID]
35. Goldenberg MM. Medical management of Parkinson's disease. Pharmacy and Therapeutics. 2008;33(10):590.
36. Senturk ZK. Early diagnosis of Parkinson's disease using machine learning algorithms. Medical hypotheses. 2020;138:109603. [DOI:10.1016/j.mehy.2020.109603] [PMID]
37. Siracusa R, Scuto M, Fusco R, Trovato A, Ontario ML, Crea R, et al. Anti-inflammatory and anti-oxidant activity of Hidrox® in rotenone-induced Parkinson's disease in mice. Antioxidants. 2020;9(9):824. [DOI:10.3390/antiox9090824] [PMID] [PMCID]
38. Zhao Z, Ning J, Bao X-q, Shang M, Ma J, Li G, et al. Fecal microbiota transplantation protects rotenone induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome. 2021;9(1):1-27. [DOI:10.1186/s40168-021-01107-9] [PMID] [PMCID]
39. Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nature Reviews Immunology. 2022;22(11):657-73. [DOI:10.1038/s41577-022-00684-6] [PMID]
40. Mosley RL, Benner EJ, Kadiu I, Thomas M, Boska MD, Hasan K, et al. Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson's disease. Clinical neuroscience research. 2006;6(5):261-81. [DOI:10.1016/j.cnr.2006.09.006] [PMID] [PMCID]
41. Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson's disease. World journal of gastroenterology: WJG. 2015;21(37):10609. [DOI:10.3748/wjg.v21.i37.10609] [PMID]
42. Boyd RJ, Avramopoulos D, Jantzie LL, McCallion AS. Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases. Journal of Neuroinflammation. 2022;19(1):223. [DOI:10.1186/s12974-022-02584-x] [PMID] [PMCID]
43. Calvo MS, Mehrotra A, Beelman RB, Nadkarni G, Wang L, Cai W, et al. A retrospective study in adults with metabolic syndrome: diabetic risk factor response to daily consumption of Agaricus bisporus (white button mushrooms). Plant Foods for Human Nutrition. 2016;71:245-51. [DOI:10.1007/s11130-016-0552-7] [PMID]
44. Nitthikan N, Leelapornpisid P, Naksuriya O, Intasai N, Kiattisin K. Potential and alternative bioactive compounds from brown Agaricus bisporus mushroom extracts for xerosis treatment. Scientia Pharmaceutica. 2022;90(4):59. [DOI:10.3390/scipharm90040059]
45. Pan X, Liu X, Zhao H, Wu B, Liu G. Antioxidant, anti-inflammatory and neuroprotective effect of kaempferol on rotenone-induced Parkinson's disease model of rats and SH-S5Y5 cells by preventing loss of tyrosine hydroxylase. Journal of Functional Foods. 2020;74:104140. [DOI:10.1016/j.jff.2020.104140]
46. Ahmed S, El-Sayed MM, Kandeil MA, Khalaf MM. Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone induced Parkinson's disease in rats. Saudi Pharmaceutical Journal. 2022;30(6):863-73. [DOI:10.1016/j.jsps.2022.03.005] [PMID] [PMCID]
47. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance.The American journal of clinical nutrition. 1993;57(5):715S-25S. [DOI:10.1093/ajcn/57.5.715S] [PMID]
48. Repetto M, Semprine J, Boveris A. Lipid peroxidation: chemical mechanism, biological implications and analytical determination. Lipid peroxidation. 2012;1:3-30. [DOI:10.5772/45943]
49. Claiborne A. Catalase activity. Handbook methods for oxygen radical research: CRC press; 2018. 283-4.
50. Devasagayam T, Tilak J, Boloor K, Sane KS, Ghaskadbi SS, Lele R. Free radicals and antioxidants in human health: current status and future prospects. Japi. 2004;52(794804):4.
51. Jiao Y, Wang Y, Guo S, Wang G. Glutathione peroxidases as oncotargets. Oncotarget. 2017;8(45):80093. [DOI:10.18632/oncotarget.20278] [PMID] [PMCID]
52. Liu J, Jia L, Kan J, Jin C-h. In vitro and in vivo antioxidant activity of ethanolic extract of white button mushroom (Agaricus bisporus). Food and chemical toxicology. 2013;51:310-6. [DOI:10.1016/j.fct.2012.10.014] [PMID]
53. Tian Y, Zeng H, Xu Z, Zheng B, Lin Y, Gan C, et al. Ultrasonic-assisted extraction and antioxidant activity of polysaccharides recovered from white button mushroom (Agaricus bisporus). Carbohydrate Polymers. 2012;88(2):522-9. [DOI:10.1016/j.carbpol.2011.12.042]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Neuroscience Updates